What is Medtronic's fair value measurement disclosure?

Medtronic (MDT) reported fair value measurement disclosure of $388M in Q4 2025.

How has Medtronic's fair value measurement disclosure changed year-over-year?

Medtronic's fair value measurement disclosure increased by 391.1% year-over-year, from $79M to $388M.

What is the long-term trend for Medtronic's fair value measurement disclosure?

Over 4 years (2021 to 2025), Medtronic's fair value measurement disclosure has grown at a 8.9% compound annual growth rate (CAGR), from $296M to $417M.

Medtronic MDT Fair Value Measurement Disclosure

Fair Value Measurement Disclosure at other companies

AmgenAMGN

——

BiogenBIIB

——

Other financials

Income statement

See full

Revenue$9.8B+9.9%

Gross profit$6.4B+10.9%

Operating income$1.9B+30.4%

Net income$1.2B+17.8%

EPS (diluted)$0.97+18.3%

Balance sheet

See full

Cash & equivalents$1.9B-12.1%

Total debt$29.2B-1.6%

Total equity$49.5B+3.0%

Total assets$93.0B+1.5%

Cash flow

See full

Operating cash flow$2.6B+1.8%

CapEx$488.0M+6.3%

Free cash flow$2.1B+0.8%

Valuation

See full

Market cap$101.86B-3.8%

Enterprise value$129.12B-3.2%

P/E21.2×-1.5×

P/S2.8×-0.4×

Profitability

See full

Gross margin65%-0.3pp

Operating margin17.8%0.0pp

Net margin13.2%-0.7pp

Returns & leverage

See full

Return on equity9.8%+0.4pp

Debt / equity0.6×0.0×

Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:DerivativeFairValueOfDerivativeLiability.

The official record: Medtronic’s 10-Q, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's fair value measurement disclosure.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medtronic's fair value measurement disclosure?: Medtronic (MDT) reported fair value measurement disclosure of $388M in Q4 2025.
How has Medtronic's fair value measurement disclosure changed year-over-year?: Medtronic's fair value measurement disclosure increased by 391.1% year-over-year, from $79M to $388M.
What is the long-term trend for Medtronic's fair value measurement disclosure?: Over 4 years (2021 to 2025), Medtronic's fair value measurement disclosure has grown at a 8.9% compound annual growth rate (CAGR), from $296M to $417M.